More cases of antibiotic resistant gonorrhoea identified in England

  09 February 2022

A woman in her 20s in London and a heterosexual couple in their 20s based in the Midlands have recently been diagnosed with a strain of N. gonorrhoeae with resistance to the antibiotic ceftriaxone.

Ceftriaxone is the main antibiotic used to treat gonorrhoea in the UK and being infected with a ceftriaxone resistant strain means that this antibiotic will not easily treat the infection. Follow-up tests are still awaited to see if treatment has been successful in these 3 recent cases.

Further public health investigations are underway but there are currently no known connections between the cases in London and the Midlands.

Ceftriaxone resistance is most common in the Asia-Pacific region and is occasionally detected in the UK in people who have visited or who have moved to the UK from this region.

Further reading: UK Government
Author(s): UK Government
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!